AKERS JOSEPH A purchased 1538.5% of their position (200K shares) of TITAN PHARMACEUTICALS INC on the open market
Open‑market purchase worth $50.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/25/2018ACC: 0001144204-18-050778
+400K
Net shares
Net buyer
$50.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
400K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+200K
Price / share
$0.25
Trade value
$50K
% of position
1538.5%
9/21/2018
13K→213K
Total
Net shares
+200K
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/21/2018 | P · Purchase | +200K | $0.25 | $50K | 1538.5% | 13K | 213K |
| Total | +200K | $50K | ||||||
Derivative Transactions1
Warrants
Direct
Converts to
common stock
200K shares
Shares
+200K
Strike price
0.25
Held after
200K
Exercisable
—
9/21/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Direct | common stock200K shares | 9/21/2018 | A · Award | +200K | 0.25 | — | 200K |